Oramed Pharmaceuticals (ORMP) Payables (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Payables of $8.7 million for Q1 2026, up 536.42% on a QoQ basis from $1.4 million in Q4 2025, and up 64.17% year-over-year from $5.3 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Payables (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Payables history runs 16 years deep, the most recent figure standing at $8.7 million for Q1 2026.
- Quarterly Payables rose 64.17% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (up 64.17% YoY) and the FY2025 annual result came in at $1.4 million, down 74.95% from the prior year.
- Payables was $8.7 million for Q1 2026 at Oramed Pharmaceuticals, up from $1.4 million in the prior quarter.
- Across five years, Payables topped out at $51.6 million in Q4 2023 and bottomed at $749000.0 in Q2 2025.
- A 5-year average of $9.9 million and a median of $4.3 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables jumped 1139.82% — and 2024, when it slumped 89.39%.
- Oramed Pharmaceuticals' Payables stood at $4.2 million in 2022, then soared by 1139.82% to $51.6 million in 2023, then sank by 89.39% to $5.5 million in 2024, then tumbled by 74.95% to $1.4 million in 2025, then jumped by 536.42% to $8.7 million in 2026.
- Business Quant data shows ORMP's Payables at $8.7 million in Q1 2026, $1.4 million in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 8.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.72 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 749,000.00 |
| Mar 31, 2025 | 5.31 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 33.30 Mn |
| Dec 31, 2023 | 51.56 Mn |
| Sep 30, 2023 | 27.56 Mn |
| Jun 30, 2023 | 831,000.00 |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Nov 30, 2021 | 4.83 Mn |
| Aug 31, 2021 | 3.85 Mn |
| May 31, 2021 | 2.86 Mn |